This week I had a great conversation with Russ Peloquin, Managing Partner of LifeSci Catalyst Partners. We dive into Russ's unique journey from aspiring exterminator (yes, you read that right!) to leading life science entrepreneur, discussing his extensive experience in commercialization, mergers, and acquisitions. Russ shares invaluable insights on the importance of marketing, fundraising strategies for biotech startups, the phases of taking a company from idea to commercialization, and the critical steps toward securing regulatory approvals. We also touch on the intersection of genome sequencing, blockchain, and AI, exploring how this convergence is set to democratize and capitalize on personal DNA. Whether you're new to biotech or an industry veteran, this episode offers a wealth of knowledge and practical advice on navigating the complex landscape of life sciences and startups.

Connect with us!

Subscribe here:

Learn more about Recruitomics Consulting

Check out our reading list

Download our free startup resources guide to grow your biotech efficiently

If you're on the job market, visit the Collaboratory Career Hub

00:00 Introduction and Early Aspirations

02:04 Journey into Medical Sales

03:37 Marketing and Commercialization Insights

05:31 Navigating Early-Stage Startups

08:39 Fundraising Strategies for Biotech Startups

15:00 Acquisitions and Exits

22:39 The Intersection of Genome Sequencing, Blockchain, and AI

29:49 Future Goals and Recommendations

31:47 Closing Remarks and Contact Information

Biotech, Blockchain, and Building Companies with Russ Peloquin, Managing Partner of LifeSci Catalyst Partners